|
|
|
Insider
Information: |
Reasons Bryan M. |
Relationship: |
Director |
City: |
Hayward |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
24,072 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$28,164 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
24,072 |
|
|
Total
Value |
$28,164 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
149.6%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Impax Laboratories Inc |
IPXL |
Chief Financial Officer |
2018-05-04 |
0 |
|
0 |
Premium* |
|
Societal CDMO, Inc |
SCTL |
Director |
2024-04-08 |
0 |
2018-05-04 |
0 |
Premium* |
|
Mallinckrodt plc |
MNK |
EVP & CFO |
2023-11-14 |
0 |
2019-04-01 |
0 |
Premium* |
|
Aclaris Therapeutics, Inc. |
ACRS |
Director |
2023-06-02 |
24,072 |
2020-03-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
51 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACRS |
Aclaris Therapeutics, Inc... |
Director |
|
2020-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,876 |
8,876 |
0 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
Director |
|
2020-06-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,333 |
16,209 |
0 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
Director |
|
2022-06-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,356 |
19,565 |
0 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
Director |
|
2023-06-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,507 |
24,072 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Acting Chief Financial Officer |
|
2012-06-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,600 |
|
- |
|
IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
|
2012-10-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
22,600 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
|
2013-04-13 |
4 |
D |
$16.46 |
$19,077 |
D/D |
(1,159) |
21,441 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
|
2013-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
14,800 |
36,241 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
|
2013-10-26 |
4 |
D |
$20.47 |
$19,221 |
D/D |
(939) |
35,302 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
|
2014-04-13 |
4 |
D |
$24.55 |
$29,853 |
D/D |
(1,216) |
34,086 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
|
2014-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
23,000 |
57,086 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
|
2014-05-15 |
4 |
D |
$25.56 |
$35,784 |
D/D |
(1,400) |
55,686 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
|
2014-10-26 |
4 |
D |
$27.80 |
$26,132 |
D/D |
(940) |
54,746 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
|
2015-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
74,746 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
|
2015-04-13 |
4 |
D |
$50.90 |
$61,335 |
D/D |
(1,205) |
73,541 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
|
2015-05-14 |
4 |
D |
$44.82 |
$96,856 |
D/D |
(2,161) |
71,380 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
|
2015-05-15 |
4 |
D |
$44.44 |
$61,816 |
D/D |
(1,391) |
69,989 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
|
2015-10-26 |
4 |
D |
$35.97 |
$46,725 |
D/D |
(1,299) |
68,690 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
|
2016-02-26 |
4 |
D |
$33.27 |
$65,143 |
D/D |
(1,958) |
66,732 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
|
2016-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
26,113 |
92,845 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
|
2016-04-13 |
4 |
D |
$35.35 |
$36,587 |
D/D |
(1,035) |
91,810 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
|
2016-05-14 |
4 |
D |
$29.18 |
$55,121 |
D/D |
(1,889) |
89,921 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
|
2016-05-15 |
4 |
D |
$29.18 |
$35,483 |
D/D |
(1,216) |
88,705 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
|
2016-10-26 |
4 |
D |
$21.35 |
$25,812 |
D/D |
(1,209) |
87,496 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
|
2017-02-26 |
4 |
D |
$14.05 |
$80,296 |
D/D |
(5,715) |
81,781 |
0 |
- |
|
51 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|